Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle East. (16th August 2022)

• Record Type: Journal Article
• Authors: Karasneh, Reema A.; Khassawneh, Basheer Y.; Al-Azzam, Sayer; Al-Mistarehi, Abdel-Hameed; Lattyak, William J.; Aldiab, Motasem; Kabbaha, Suad; Hasan, Syed Shahzad; Conway, Barbara R.; Aldeyab, Mamoon A.
• Other Names: B. D. Parameshachari Academic Editor.
• Is Part Of: International journal of clinical practice. Volume 2022(2022)
• Publication Date: 2022-08-16
• Subjects: Clinical medicine -- Periodicals; Medicine -- Periodicals; 610.5
• DOI: 10.1155/2022/9617319
• Languages: English
• ISSNs: 1368-5031

Abstract

Abstract : This study aimed to assess the risk factors for COVID-19 mortality among hospitalized patients in Jordan. All COVID-19 patients admitted to a tertiary hospital in Jordan from September 20, 2020, to August 8, 2021, were included in this study. Demographics, clinical characteristics, comorbidities, and laboratory results were extracted from the patients' electronic records. Multivariable logistic and machine learning (ML) methods were used to study variable importance. Out of 1, 613 COVID-19 patients, 1, 004 (62.2%) were discharged from the hospital (survived), while 609 (37.8%) died. Patients who were of elderly age (>65 years) (OR, 2.01; 95% CI, 1.28–3.16), current smokers (OR, 1.61; 95%CI, 1.17–2.23), and had severe or critical illness at admission ((OR, 1.56; 95%CI, 1.05–2.32) (OR, 2.94; 95%CI, 2.02–4.27); respectively), were at higher risk of mortality. Comorbidities including chronic kidney disease (OR, 2.90; 95% CI, 1.90–4.43), deep venous thrombosis (OR, 2.62; 95% CI, 1.08–6.35), malignancy (OR, 2.22; 95% CI, 1.46–3.38), diabetes (OR, 1.31; 95% CI, 1.04–1.65), and heart failure (OR, 1.51; 95% CI, 1.02–2.23) were significantly associated with increased risk of mortality. Laboratory abnormalities associated with mortality included hypernatremia (OR, 11.37; 95% CI, 4.33–29.81), elevated aspartate aminotransferase (OR, 1.81; 95% CI, 1.42–2.31), hypoalbuminemia (OR, 1.75; 95% CI, 1.37–2.25), and low platelets level (OR, 1.43; 95% CI, 1.05–1.95). Several demographic, clinical, and laboratory risk factors for COVID-19 mortality were identified. This study is the first to examine the risk factors associated with mortality using ML methods in the Middle East. This will contribute to a better understanding of the impact of the disease and improve the outcome of the pandemic worldwide.